Pathological and therapeutic distinctions in HUS/TTP-Reference-Cited by-同舟云学术

Pathological and therapeutic distinctions in HUS/TTP

Published:2000-02 Issue:9202 Volume:355 Page:497
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Laurence Jeffrey

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak;Dundas;Lancet,1999

2. Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome;Laurence;Sem Hematol,1997

3. Thrombotic thrombocytopenic purpura associated with ticlopidine;Bennett;Ann Intern Med,1998

4. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura;Dang;Blood,1999

5. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome;Furlan;N Engl J Med,1998

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Non-Invasive Laboratory Panel as a Diagnostic and Prognostic Biomarker for Thrombotic Microangiopathy: Development and Application in a Chinese Cohort Study;PLoS ONE;2014-11-05

2. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients;Journal of Hematology & Oncology;2008-12

3. Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanism;Pediatric Nephrology;2005-07-27

4. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor;Blood;2001-11-01

5. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome;Pediatric Nephrology;2001-10-01